| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.0009 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.002 |